## **Core Concept**
Gluten-sensitive enteropathy, also known as celiac disease, is a chronic autoimmune disorder primarily affecting the small intestine. It is triggered by the ingestion of **gluten**, a protein found in wheat, barley, and rye, leading to mucosal damage and malabsorption. The condition is strongly associated with specific genetic markers.

## **Why the Correct Answer is Right**
The correct answer, **HLA-DQ2**, is the genetic marker most strongly associated with gluten-sensitive enteropathy or celiac disease. The HLA-DQ2 and HLA-DQ8 haplotypes are considered the primary genetic risk factors for the development of celiac disease. **HLA-DQ2** is found in approximately 90-95% of patients with celiac disease, making it a crucial diagnostic criterion and a significant genetic predisposition marker.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain genetic markers are associated with an increased risk of various autoimmune diseases, they are not as strongly linked to gluten-sensitive enteropathy as **HLA-DQ2**.
- **Option B:** This option is incorrect because, although **HLA-DQ8** is another genetic marker associated with celiac disease, it is present in a smaller percentage of patients compared to **HLA-DQ2**.
- **Option D:** This option does not represent a recognized genetic marker for gluten-sensitive enteropathy.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with celiac disease are at an increased risk of developing other autoimmune disorders, such as type 1 diabetes, autoimmune thyroid disease, and rheumatoid arthritis. Screening for celiac disease is recommended in these high-risk groups. The presence of **HLA-DQ2** or **HLA-DQ8** can support the diagnosis but is not definitive on its own due to the presence of these haplotypes in a portion of the healthy population.

## **Correct Answer:** . **HLA-DQ2**